A short dasatinib and quercetin treatment is sufficient to reinstate potent adult neuroregenesis in the aged killifish

The young African turquoise killifish has a high regenerative capacity, but loses it with advancing age, adopting several aspects of the limited form of mammalian regeneration. We deployed a proteomic strategy to identify pathways that underpin the loss of regenerative power caused by aging. Cellular senescence stood out as a potential brake on successful neurorepair. We applied the senolytic cocktail Dasatinib and Quercetin (D + Q) to test clearance of chronic senescent cells from the aged killifish central nervous system (CNS) as well as rebooting the neurogenic output. Our results show that the entire aged killifish telencephalon holds a very high senescent cell burden, including the parenchyma and the neurogenic niches, which could be diminished by a short-term, late-onset D + Q treatment. Reactive proliferation of non-glial progenitors increased substantially and lead to restorative neurogenesis after traumatic brain injury. Our results provide a cellular mechanism for age-related regeneration resilience and a proof-of-concept of a potential therapy to revive the neurogenic potential in an already aged or diseased CNS.



Thx for sharing this. Has anyone on this Forum tried a D + Q protocol? I think one that is being used in clinical trials for ALS and other neurodegenerative conditions is uses is 2 or 3 days of 100mg D and 500 or 1000mg of Q every other week for 6 weeks.


1 Like

We have a few threads discussing this, with some people having done it:

Here: Senolytic Therapy: What are you doing?

Here: Fisetin - The Mayo Clinic Senolytics Protocol?

1 Like

Sorry - I missed these in a search. Awesome- thanks!